HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Health Food Industry Proposes Three-Tier Claims System To Break Botanicals Deadlock

Executive Summary

Attempting to find a way out of the current EU botanicals stalemate, the European Health Product Manufacturers Federation (EHPM) outlines a three-level framework for the assessment of health claims made for herbal food supplements.

You may also be interested in...



Europe's Botanicals Deadlock ‘Unlawful,’ Claims Industry Lawyer

The European Commission’s obvious passivity” with regards to the long-standing botanical health claims deadlock is illegal and violates the provisions of the EU Health Claims Regulation,” argues the German Pharmaceutical Industry Association, on the basis of a legal opinion provided by former constitutional judge Udo Di Fabio.

Resolving Botanicals Deadlock 'Not A Priority' For European Commission

Tensions between industry and the European Commission on the issue of  health claims for botanical food supplements were aired on the second day of the BAH's High Level Conference on the Future of Medicines, with the EC saying the EU Green Deal is now higher up on its list of priorities for the foreseeable future. 

European Commission Suggests ‘Traditional Use’ Could Resolve Botanicals Deadlock

Five years in the making, the European Commission delivers its assessment of the botanical ingredients in food supplements situation, suggesting that 'traditional use' may be a way out of the deadlock. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150995

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel